Key result
Mutations in the hNav1.5 channel, specifically E1295R and R1739E, altered steady-state fast and slow inactivation, suggesting that extracellular loop IVP2-S6 is involved in motion transmission from VSD-III to the inactivation gates.
Why the study?
The interface between extracellular loop IVP2-S6 and voltage-sensing domain III in cardiac sodium channel hNav1.5 is a hotspot for arrhythmia-associated mutations, but atomic mechanisms of channel dysfunction caused by these mutations remain unknown.
The study provides molecular insights into how mutations at the interface of loop IVP2-S6 and VSD-III in the cardiac sodium channel hNav1.5 alter inactivation gating, which may explain their association with cardiac arrhythmias like Brugada syndrome.
Motion transmission from voltage sensors to inactivation gates is an important problem in the general physiology of ion channels. In a cryo-EM structure of channel hNa v 1.5, residues N1736 and R1739 in the extracellular loop IVP2-S6 approach glutamates E1225 and E1295, respectively, in the voltage-sensing domain III (VSD-III). ClinVar-reported variants E1230K, E1295K, and R1739W/Q and other variants in loops IVP2-S6, IIIS1-S2, and IIIS3-S4 are associated with cardiac arrhythmias, highlighting the interface between IVP2-S6 and VSD-III as a hot spot of disease mutations. Atomic mechanisms of the channel dysfunction caused by these mutations are unknown. Here, we generated mutants E1295R, R1739E, E1295R/R1739E, and N1736R, expressed them in HEK-293T cells, and explored biophysical properties. Mutation E1295R reduced steady-state fast inactivation and enhanced steady-state slow inactivation. In contrast, mutation R1739E slightly enhanced fast inactivation and attenuated slow inactivation. Characteristics of the double mutant E1295R/R1739E were rather similar to those of the wild-type channel. Mutation N1736R attenuated slow inactivation. Molecular modeling predicted salt bridging of R1739E with the outermost lysine in the activated voltage-sensing helix IIIS4. In contrast, the loss-of-function substitution E1295R repelled R1739, thus destabilizing the activated VSD-III in agreement with our data that E1295R caused a depolarizing shift of the G-V curve. In silico deactivation of VSD-III with constraint-maintained salt bridge E1295-R1739 resulted in the following changes: 1) contacts between IIIS4 and IVS5 were switched; 2) contacts of the linker-helix IIIS4-S5 with IVS5, IVS6, and fast inactivation tripeptide IFM were modified; 3) contacts of the IFM tripeptide with helices IVS5 and IVS6 were altered; 4) mobile loop IVP2-S6 shifted helix IVP2 that contributes to the slow inactivation gate and helix IVS6 that contributes to the fast inactivation gate. The likelihood of salt bridge E1295-R1739 in deactivated VSD-III is supported by Poisson–Boltzmann calculations and state-dependent energetics of loop IVP2-S6. Taken together, our results suggest that loop IVP2-S6 is involved in motion transmission from VSD-III to the inactivation gates.
No takes yet. Share an insight, caveat, or question.
Zaytseva et al. (2021) studied Cardiac arrhythmias (Brugada syndrome). Site-directed mutagenesis (E1295R, R1739E, E1295R/R1739E, N1736R) of hNav1.5 vs. Wild-type hNav1.5 was evaluated on Electrophysiological properties (steady-state activation and inactivation). Mutations in the hNav1.5 channel, specifically E1295R and R1739E, altered steady-state fast and slow inactivation, suggesting that extracellular loop IVP2-S6 is involved in motion transmission from VSD-III to the inactivation gates.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: